In the pharmaceutical industry, the safety and reliability of every dose depend on one critical foundation: Current Good Manufacturing Practices (cGMP). These internationally recognized standards are designed to ensure that medicines are consistently produced with the highest levels of quality, safety, and efficacy.

cGMP regulates every step of manufacturing from sourcing raw materials to final packaging so that patients receive medicines they can trust. Without such controls, the risks increase significantly. Contamination may harm patients, inconsistencies in drug strength can affect treatment outcomes, and product recalls can erode trust and delay access to life-saving therapies.

At Coral Drugs, we view cGMP as more than a regulatory requirement. For us, it represents a deep responsibility to patients, healthcare providers, and partners worldwide. By embedding cGMP principles into every aspect of our operations, we ensure consistency, reliability, and safety in all our Active Pharmaceutical Ingredients (APIs).

This commitment has been recognized globally. Most recently, our facilities in Sonipat, Haryana (India) received Establishment Inspection Reports (EIR) from the US FDA, further validating our dedication to world-class manufacturing practices.

With over 25 years of expertise, Coral Drugs continues to support global pharma companies with safe, reliable, and sustainable APIs.

Follow our journey of quality and innovation on LinkedIn

‍